Literature DB >> 28751429

Energy drinks give you wings but also an abnormal exercise test.

Tawfiqur R Choudhury1, Muhammad A Abdool1, Gavin Galasko1.   

Abstract

This is the case of a 53-year-old man with known coronary artery disease who underwent two exercise treadmill tests (ETT). The first test, which yielded an abnormal result, was undertaken shortly after he had drunk two cans of Red Bull, a popular energy drink (ED). A second ETT was undertaken 1 week later by the same team without EDs on board and the test result was normal. This case suggests that drinking EDs prior to an ETT could lead to a false positive result and should be discouraged prior to exercise testing. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Arrhythmias; Clinical Diagnostic Tests; Ischaemic Heart Disease; Unwanted Effects / Adverse Reactions

Mesh:

Year:  2017        PMID: 28751429      PMCID: PMC5614011          DOI: 10.1136/bcr-2017-220017

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  With which mechanism the overuse of energy drinks may induce acute myocardial ischemia?

Authors:  Hossein Sanaei-Zadeh
Journal:  Cardiovasc Toxicol       Date:  2012-09       Impact factor: 3.231

Review 2.  Effect of altitude on the heart and the lungs.

Authors:  Peter Bärtsch; J Simon R Gibbs
Journal:  Circulation       Date:  2007-11-06       Impact factor: 29.690

3.  Caffeine decreases exercise-induced myocardial flow reserve.

Authors:  Mehdi Namdar; Pascal Koepfli; Renate Grathwohl; Patrick T Siegrist; Michael Klainguti; Tiziano Schepis; Raphael Delaloye; Christophe A Wyss; Samuel P Fleischmann; Oliver Gaemperli; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

4.  Detrimental effects of energy drink consumption on platelet and endothelial function.

Authors:  Matthew I Worthley; Anisha Prabhu; Paolo De Sciscio; Carlee Schultz; Prashanthan Sanders; Scott R Willoughby
Journal:  Am J Med       Date:  2010-02       Impact factor: 4.965

Review 5.  Journeys to high altitude--risks and recommendations for travelers with preexisting medical conditions.

Authors:  Kelly Mieske; Gerard Flaherty; Timothy O'Brien
Journal:  J Travel Med       Date:  2010 Jan-Feb       Impact factor: 8.490

6.  Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction.

Authors:  Ana Baylin; Sonia Hernandez-Diaz; Edmond K Kabagambe; Xinia Siles; Hannia Campos
Journal:  Epidemiology       Date:  2006-09       Impact factor: 4.822

7.  Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease.

Authors:  J-P Schmid; M Noveanu; R Gaillet; G Hellige; A Wahl; H Saner
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

8.  A case of caffeine-induced coronary artery vasospasm of a 17-year-old male.

Authors:  Ryan E Wilson; Herman S Kado; Rohan Samson; Alan B Miller
Journal:  Cardiovasc Toxicol       Date:  2012-06       Impact factor: 3.231

Review 9.  The autonomic nervous system at high altitude.

Authors:  Roger Hainsworth; Mark J Drinkhill; Maria Rivera-Chira
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

10.  Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls.

Authors:  Mehdi Namdar; Tiziano Schepis; Pascal Koepfli; Oliver Gaemperli; Patrick T Siegrist; Renate Grathwohl; Ines Valenta; Raphael Delaloye; Michael Klainguti; Christophe A Wyss; Thomas F Lüscher; Philipp A Kaufmann
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

View more
  1 in total

Review 1.  Energy Drink-Associated Electrophysiological and Ischemic Abnormalities: A Narrative Review.

Authors:  Diana X Cao; Kimberly Maiton; Javed M Nasir; N A Mark Estes; Sachin A Shah
Journal:  Front Cardiovasc Med       Date:  2021-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.